E 130
Pill imprint E 130 has been identified as Bumetanide 2 mg.
Bumetanide is used in the treatment of edema; pulmonary edema; ascites and belongs to the drug class loop diuretics. Risk cannot be ruled out during pregnancy.
Bumetanide 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Bumetanide Images
- Imprint:
-
E 130
- Strength:
- 2 mg
- Color:
- Beige
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
corn starch
magnesium stearate
microcrystalline cellulose
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
magnesium silicate
- Drug Class:
- Loop diuretics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00185-0130
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00378-0417 | Mylan Inc. |
| 51079-0893 | UDL Laboratories Inc |
| 54868-4352 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More Bumetanide resources
- Bumetanide (Wolters Kluwer)
- Bumetanide Tablets (Wolters Kluwer)
- bumetanide (Cerner Multum)
- bumetanide (Micromedex) - Includes Dosage Information
- bumetanide Injection (Micromedex) - Includes Dosage Information
- Bumetanide (AHFS DI)
- Bumetanide (FDA)
- Bumetanide Tablets (FDA)
- Bumetanide (Wolters Kluwer)


